US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
XBT Provider AB Open Ended Ethereum Tracker (GM) (CETHF) 銘柄情報

XBT Provider AB Open Ended Ethereum Tracker (GM) (CETHF)

34.80

0.00

(0.00%)

終了 7月11日 5:00AM

XBT Provider AB Open Ended Ethereum Tracker (GM) (CETHF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

34.80

( - )

買値

34.80

売値

34.80

出来高

-

平均取引量 (3 か月)

US$ 0

財務取引量

-

0.00 日の範囲 0.00

17.0754 52 週間の範囲 34.80

時価総額

企業価値

-

前日終値

34.80

始値

-

時刻

最終取引時間

VWAP

-

歳入

4.98M

純利益

1.58M

発行済株式数

-

浮動株比率 (%)

-

機関投資家保有比率 (%)

-

配当利回り

PER

-

株価売上高倍率 (PSR)

-

1 株当たり利益 (EPS)

-

ベータ

-

CoinShares XBT Provider AB (Publ), a special purpose vehicle, engages in the issuance of non-equity linked certificates designed to track the performance of a specific crypt-asset, such as Bitcoin or Ether. It is also involved in hedging activities related to issued certificates. Its products includ... CoinShares XBT Provider AB (Publ), a special purpose vehicle, engages in the issuance of non-equity linked certificates designed to track the performance of a specific crypt-asset, such as Bitcoin or Ether. It is also involved in hedging activities related to issued certificates. Its products include bitcoin tracker one and tracker euro; and ether tracker one and tracker euro. CoinShares XBT Provider AB (Publ) was incorporated in 2015 and is headquartered in Stockholm, Sweden. 詳細を表示

セクター

-

業界

-

本社

Bristol, United Kingdom

設立

2026

XBT Provider AB Open Ended Ethereum Tracker (GM) is listed in the sector of the その他OTC with ticker CETHF. The last closing price for XBT Provider AB Open End... (GM) was US$34.80. Over the last year, XBT Provider AB Open End... (GM) shares have traded in a share price range of US$ 17.0754 to US$ 34.80.

XBT Provider AB Open End... (GM) currently has shares in issue.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	34.8	34.8	34.8	0	0	CS
26	0	0	34.8	34.8	34.8	0	0	CS
52	17.72465	103.802557488	17.07535	34.8	17.07535	305	34.8	CS
156	17.72465	103.802557488	17.07535	34.8	17.07535	223	34.8	CS
260	17.72465	103.802557488	17.07535	34.8	17.07535	200	33.20093278	CS

CETHF - Frequently Asked Questions (FAQ)

What is the current XBT Provider AB Open Ended Ethereum Tracker (GM) share price?

The current share price of XBT Provider AB Open Ended Ethereum Tracker (GM) is US$ 34.80

What is the 1 year trading range for XBT Provider AB Open Ended Ethereum Tracker (GM) share price?

XBT Provider AB Open Ended Ethereum Tracker (GM) has traded in the range of US$ 17.0754 to US$ 34.80 during the past year

What is the registered address of XBT Provider AB Open Ended Ethereum Tracker (GM)?

The registered address for XBT Provider AB Open Ended Ethereum Tracker (GM) is Kendal House, Bristol, BS8 2NX

rosemountbomber

rosemountbomber 14分前

It is the consensus view because company management and the FDA have not given us reason to believe otherwise. As far as the AI take in your following post how ridiculous that the 2nd CRL to cite the same deficiencies as the first. They never did a second inspection to discover those deficiencies.

Genz2

https://www.macrumors.com/2026/07/09/apple-prismml-larger-on-device-ai-models/

Has Tesla/SpaceXAI thought about working with a company like PrismML so that they could efficiently run Grok/MacroHard and use less memory in Dell, HP or Lenovo computers? The PrismML could reduce the memor

Slojab

Slojab 16分前

Pretty ridiculous, huh? You should be able to have a negative market cap. 🤣

smoki

F’ing A ….blasting off get your free ride NOW!!! $$$$$$$$$ …Blozf goos Blo ^^^^^^^^^^^^:))))))

BahamaPete

BahamaPete 26分前

Thanks OCKHAM's RAZOR, I added your links to my DD post. Go $TKOI

Helter Skelter

Helter Skelter 35分前

😆 "accurately captures one of the most critical underappreciated alliances..."

https://investorshub.advfn.com/uimage/uploads/2026/7/10/opnhmBB_Can_u_say_MONOPOLY_071026.png

🤑 $BB Where Nvidia Goes We Go $NVDA 🤑

Twiggs333

Twiggs333 42分前

CMPS Compass Pathways: A Structural Mispricing in Plain Sight?

Extremely good explanation of the value of this company by a Stanford Professor.

https://x.com/kevin__mak/status/2075541715272790373

Popeye

Popeye 42分前

Yeah, agreed. That was a shot of the dark guess of the discount for the Reg A and .08 would certainly move the numbers in the favor of the shareholder.
Unknowns are 1. What will the discount be and 2. How much will Korenko raise? (Doesn’t have to raise the entire $9 million now - maybe raise

Twiggs333

Twiggs333 44分前

Compass Pathways: A Structural Mispricing in Plain Sight?

https://x.com/kevin__mak/status/2075541715272790373

CA Market News

CA Market News 47分前

Lion One Announces Closing of Second Tranche of Non-Brokered Private Placement of Convertible Debenture Units and Units for Aggregate Gross Proceeds of $17.5 MillionJuly 10, 2026 11:14 PM
Newsfile

Genz2

Sorry, misspelled Greg’s last name in the previous post!!! It should be Kazmierczak!!

Gus1212

Gus1212 56分前

If this rejection theory is correct, I believe it was just a tactic to stall our approval process.
Sounds too simple, doesn't it!

Maybe paid for by you know who, big pharma.

They all know that DCVAX works; they are not dummies.
Why did they stall? Cou

Whalatane

Whalatane 1時間前

A Fable 5 analysis
Synthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsSynthesized FDA timeline risks, TDAPA reimbursement implications, and dilution concernsGood context to layer in.
Here's the deeper risk breakdown on those three fronts.

LTR

I think a suitable punishment for these guys would be to lock them up in ILT's vault and throw away the key.

Real McCoy

Real McCoy 1時間前

Well yeah this one has the most lies.

3rd attempt: you ok with lies, yes or no?

pos_stock_hoarder

pos_stock_hoarder 1時間前

New York Dolls - Looking for a Kiss

https://youtu.be/GvmvMFXWzc8

Genz2

Genz2 1時間前

https://techcrunch.com/2026/07/10/us-cyber-agency-cisa-had-to-build-its-incident-playbook-during-the-incident-agency-reveals/

According to Krebs, the researcher tried to alert the contractor but didn’t hear back. Only after Krebs contacted CISA did the agency take the repository offli

boston127

boston127 1時間前

Hey,

Thanks for the links you sent me. My PC blocked all of the URLs due to malware protection. I'm still in GNIS and the other one. I was up but they have dive bombed quite rapidly. Now, in the RED. Both companies are interesting.

LTR

I have an idea AF may turn up in discovery when the dots are lined up and connected. AF may look to be a witness in order to avoid being a defendent.

conix

conix 1時間前

Non-promotional information until there is a press release is a wise move.

CatfishHunter

CatfishHunter 1時間前

We should have news of next step well before years end. Vivos is already approved by FDA to start the EFS. Mayo Clinic needs to review and sign off on the approved conditions for the IRB and that’s just a formality. EFS could start as early as August. And 30 day patient status report about 45 days a

Philosophical Trader

Philosophical Trader 1時間前

How is this doing? This was a great runner with a 2 year cup and handle.

nwtf

nwtf 1時間前

You really dont have a clue what you are talking about. Just stop.

XBT Provider AB Open End... (GM)

Jpmorgan Betabuilders Ms...

Btp Fx 4.65% Oct55 Eur

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。